CURE® Expert Connections

Expert Connections is a video series designed to help patients and their loved ones along their cancer care journey by offering information and expert advice from leaders in oncology care. Expert medical professionals share their knowledge and insights on an array of topics to allow for a better understanding of what to expect following a cancer diagnosis. Expert Connections hopes to bridge the gap between patients and oncology professionals to ensure no question is left unanswered.

Updates in Diagnosis, Treatment, and Management of Metastatic Uveal Melanoma

August 10th 2022

Sunandana Chandra, MD, MS, delves into the evolution of the metastatic uveal melanoma treatment landscape and the discussions she has with patients during treatment decision-making.

Role of Tivozanib in Renal Cell Carcinoma (RCC)

June 20th 2022

Thomas Hutson, DO, PharmD discusses the role of tivozanib in the treatment landscape for patients with renal cell carcinoma.

NSCLC Targeted Therapy: EGFR Exon 20 Mutation

April 29th 2022

An expert oncologist and a patient advocate work together to discuss the importance of EGFR exon20 treatment in metastatic non-small cell lung cancer.

Role of Adjuvant Therapy in Early Non-Small Cell Lung Cancer

January 10th 2022

Jessica Donington, MD, MSCR, and Martin Dietrich, MD, PhD, have a thorough discussion on the management of early non-small cell lung cancer, including treatment options and the role of adjuvant therapy.

HER2-positive Breast Cancer: Jocelyn’s Story

October 22nd 2021

Expert oncologist Julie Fisher, MD, is joined by her patient Jocelyn Mueller, who shares her personal journey with HER2-positive breast cancer.

Management of Advanced Non–Small Cell Lung Cancer

September 24th 2021

A discussion pertaining to the significance of biomarker testing and precision medicine in non–small cell lung cancer.

Multiple Myeloma: Marcella’s Story

August 27th 2021

Expert hematologist/oncologist Kenneth Shain, MD, PhD, is joined by Marcella Worrell, a survivor of multiple myeloma, who shares her story of diagnosis, treatment, and support.

Renal Cell Carcinoma

June 29th 2021

Thomas E. Hutson, DO, PharmD, shares insight on the role of combination therapy and recent advances for the management of renal cell carcinoma.

Locally Advanced Basal Cell Carcinoma

June 29th 2021

Anna C. Pavlick, DO, discusses locally advanced basal cell carcinoma and various treatment options for patients and caregivers.

Triple-Negative Breast Cancer: Latasha’s Story

June 15th 2021

A survivor of triple-negative breast cancer, Latasha Jordan, and an expert breast oncologist, Aditya Bardia, MD, MPH, provide key insights into the patient experience in triple-negative breast cancer and highlight the role of clinical trials in the current treatment landscape.

Multiple Myeloma: Donna's Journey

May 21st 2021

Cristina Gasparetto, MD, is joined by her patient, Donna, as they discuss her particular experience with diagnosis and treatment of multiple myeloma.

The Role of Tumor Infiltrating Lymphocyte (TIL) Therapy in NSCLC

May 11th 2021

An expert in thoracic oncology, Adam J. Schoenfeld, MD, provides key insight into the use of cell therapy in non-small cell lung cancer after first-line treatment and highlights the potential for tumor-infiltrating lymphocyte (TIL) therapy depending on results from ongoing clinical trials.

Biomarker Testing in Lung Cancer

May 10th 2021

Insight regarding the role of comprehensive biomarker testing non-small cell lung cancer to help individualize therapy.

Multiple Myeloma: Beth's Story

April 14th 2021

This series follows one patient’s journey with multiple myeloma through diagnosis and treatment information, provided by Elie Fahed, MD.

Treating HER2+ Metastatic Breast Cancer: Caitlin’s Story

March 16th 2021

Sara A. Hurvitz, MD, discusses information about HER2+ metastatic breast cancer with one of her patients, Caitlin Flanagan, as she shares her personal journey with breast cancer.

Management of Myelodysplastic Syndromes

December 17th 2020

CAR T Therapy for Relapsed/Refractory DLBCL: Brian’s Story

November 25th 2020

Treating With Venetoclax for Chronic Lymphocytic Leukemia: Samantha’s Story

October 14th 2020

PARP Inhibition in Recurrent Prostate Cancer

September 28th 2020

Expert Connections: Hereditary Prostate Cancer

September 16th 2020

Understanding Relapsed/Refractory Follicular Lymphoma

August 14th 2020

Considering Immunotherapy for Cutaneous Squamous Cell Carcinoma

December 23rd 2019

Overcoming the Odds: Steven's Journey with Stage IV RCC

June 24th 2019

An Opportunity for Treatment in Relapsed Hairy Cell Leukemia

June 18th 2019

ADT in Prostate Cancer: Managing Cardiovascular Risk

May 10th 2019

Locally Advanced NSCLC: Optimizing Outcomes With Immunotherapy

April 30th 2019

BTK Inhibition for Waldenstrom Macroglobulinemia

February 15th 2019

Improving the Outlook of Patients with Follicular Lymphoma

January 21st 2019

Evaluating Therapeutic Options in Chronic Lymphocytic Leukemia

December 27th 2018

Understanding PARP Inhibition in BRCA-Mutated Breast Cancer

December 4th 2018